Chris Tankersley

Chris Tankersley has held various roles in the field of clinical science and development. Chris is currently the Executive Director of Clinical Science at Prelude Therapeutics, a position they have held since July 2023. Prior to that, they served as Senior Director of Clinical Science at BeiGene starting in June 2019. From June 2014 to June 2019, Chris worked as the Director of Clinical Science at Clovis Oncology. Chris also has experience with Amgen, where they served as Director of Clinical Development from June 2011 to May 2014 and as Senior Manager of Clinical Research Program Management from October 2005 to May 2011. Chris began their career at Quintiles as a Lead Clinical Research Associate from 1997 to 1999.

Chris Tankersley earned a Bachelor of Science degree in Animal Physiology and Neuroscience from UC San Diego, which they attended from 1991 to 1995. Chris later pursued a Master of Science degree in Entomology at the University of Nebraska-Lincoln, where they studied from 2014 to 2021.